Clinical trials
Recruiting Phase 1 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,548 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 9 |
| 2020 | 19 |
| 2021 | 33 |
| 2022 | 61 |
| 2023 | 160 |
| 2024 | 354 |
| 2025 | 533 |
| 2026 | 365 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 1,548 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 34 |
| Zhejiang University | 32 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 28 |
| West China Hospital | 28 |
| Chongqing Precision Biotech Co., Ltd | 24 |
| Institute of Hematology & Blood Diseases Hospital, China | 21 |
| Ruijin Hospital | 20 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 20 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 18 |
| BeOne Medicines | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 59 |
| Lupus Erythematosus, Systemic | 58 |
| Carcinoma, Non-Small-Cell Lung | 57 |
| Neoplasms | 53 |
| Multiple Myeloma | 47 |
| Leukemia, Myeloid, Acute | 42 |
| Breast Neoplasms | 41 |
| Colorectal Neoplasms | 38 |
| Lymphoma, B-Cell | 33 |
| Carcinoma, Hepatocellular | 32 |
Trials
Showing 1 to 25 of 1,548. Each trial links to its page on Pharma Observatory.
1,448 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.